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Introduction: What Kills Children?
In a report released in September 2013, the United Nations Children’s
Fund (UNICEF), together with the World Health Organization (WHO) and
World Bank identified substantial progress in reducing the number of
children who die before their fi
fifth birthday.1 In the more than 20 years
between 1990 and 201
2012 the number of such deaths worldwide has
decreased from 12.6 million to 6.6 million (Figure 1),, almost a 50%
50 drop,
with approximately one
one-half of the these deaths occurring in just five
countries – three in Asia, India, Pakistan and China, and two in SubSub
Saharan Africa, Democratic Republic of Congo and Nigeria.1
Figure 1. Decline in under--five child mortality since 1990. UNICEF analysis based on the
United Nations Inter-agency
agency Group for Child Mortality Estimation (IGME), Levels and
Trends
in
Child
Mortality:
Report
2013,
UNICEF,
New
York,
2013.

A key factor in the dramatic gains in reducing child mortality over
the
e last two decades has been an increase both in the delivery of existing
vaccines and the development of new vaccines. With regards to enhanced
delivery, there has been a huge increase in the number of infants who
receive their childhood vaccines, especially measles vaccine (with a 74%
reduction in global measles deaths) and Hib (Haemophilus
Haemophilus influenzae
influenza type
2
B) vaccine, while in paral
parallel
lel new vaccines for pneumococcal pneumonia
and rotavirus diarrhea have been developed. A major organization in
promoting these vaccines both for delivery and development has been the
GAVI Alliance (formerly Global Alliance for Vaccines and Immunisation)
Immunisation –
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a partnership of WHO, UNICEF, World Bank, the Bill & Melinda Gates
Foundation, donor governments, developing countries, and international
finance agencies, which was launched in January 2000 in order to fund
vaccines for children in the world’s 70 poorest countries.3 Approximately
2.5 million children’s lives may be saved annually through these activities.2
If we look at what still kills under-five children today, mostly in developing
countries in Sub-Saharan Africa, South and Southeast Asia, and a few of
the poorest Latin American countries (Figure 2), almost one-half of the
deaths occurs during the neonatal period (first 28 days of life) especially
from pre-term birth and intrapartum-related complications. However,
approximately 1.5 million children still die (before their fifth birthday)
annually from vaccine-preventable diseases.2 In response, in 2010 the Bill
& Melinda Gates Foundation helped to launch the Decade of Vaccine
(DoV) collaboration to expand political commitment for the use of vaccines
and financing of immunization services, creating market incentives to
ensure a reliable supply of affordable vaccines, and fostering a scientific
infrastructure for producing vaccines that target high priority diseases.2
Such activities are expected to produce important additional gains in the
reduction in childhood deaths.
Figure 2. Global map of under-five childhood mortality rates in 2012, UNICEF analysis
based on the United Nations Inter-agency Group for Child Mortality Estimation (IGME),
Levels and Trends in Child Mortality: Report 2013, UNICEF, New York, 2013. (note: this
map is stylized and not to scale. It does not reflect a position by UN IGME agencies on
the legal status of any country or territory or the delimitation of any frontiers.)
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Lagging Behind: The Pediatric Tropical Diseases
In contrast to the gains resulting from the GAVI Alliance and the DoV, with
a few exceptions the overall prevalence of the leading tropical diseases of
children such as dengue, malaria, schistosomiasis, soil-transmitted
helminth infections, trachoma, and visceral leishmaniasis has not
substantially decreased over the last twenty years, and in some cases
may even be increasing. Shown in Table 1 are the major pediatric tropical
infections ranked by the estimated number of cases, together with the
number of deaths that result from these conditions and the number of
disability-adjusted life years (DALYs), a metric that considers both the
number of years of life lost from premature death and years lost through
disability.4-12 DALYs are an important metric for pediatric tropical diseases
because many of them are not major killers, so much as important
disablers affecting child development, fitness, future intelligence, and
wage earning. Below Table 1 is a brief summary of the major pediatric
tropical diseases.
Table 1. Leading Tropical Infections that Disproportionately Affect Children Ranked by
number of estimated cases, DALYs, Deaths

Disease

Estimated
no. cases

DALYs

Soil-transmitted
helminth infections

890 million

5.2 million

2,700

5-8

Dengue

390 million

0.8 million

14,700

5-7, 9

Malaria

216 million

82.7 million

655,0001,169,500

5-7, 10

Schistosomiasis

207 million

3.3 million

11,700

5-7, 11

21 million

0.3 million

0

5-7, 12

3.3 million

51,600

5-7, 13

95.6 million

735,7001,250,200

Trachoma
Visceral
leishmaniasis

0.2-0.4 million

Total

1.7 billion

Deaths

Reference

*With the exception of the children who require treatment for soil-transmitted
helminth infections these numbers reflect both adults and children although
children account for majority of the disease burden.
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Soil-transmitted helminth (STH) infections. STH infections
include ascariasis – roundworm infection, trichuriasis – whipworm
infection, and hookworm infection. Although they are not killer diseases,
these intestinal nematode infections disproportionately affect preschool
and school-aged children, leading to growth stunting and intellectual and
cognitive delays, and even reductions in future economic potential.7,13-16
The WHO currently estimates that more than 800 million children, a large
percentage of children in developing countries, require annual
anthelminthic treatments – deworming.7 STH infections are widely
prevalent wherever rural poverty intersects tropical climates in Africa,
South and Southeast Asia, and Latin America.13
Dengue. Dengue fever is a flavivirus infection transmitted by Aedes
mosquitoes that causes high fever, headache, rash, and joint pain, and in
severe cases leads to hemorrhage, shock, and death.16 Children tend to
suffer from the greatest morbidity and mortality.16 There has been a huge
increase in the number of dengue cases annually, with new estimates
indicating that as many as 390 million cases occur. Among the factors
contributing to the emergence of dengue are urbanization, environmental
degradation, lack of mosquito control, increased air travel, and possibly
climate change.8,16 India and South Asia, the Pacific islands, and coastal
Latin America, including Brazil and Central America, are currently
experiencing some of the largest outbreaks of dengue.
Malaria. Malaria is a parasitic protozoan infection transmitted by
Anopheles mosquitoes. It remains one of the great childhood killers,
especially among children between the ages of six months and five
years.9,17 An estimated 216 malaria infections occur annually, and
between 655,000 and 1.2 million people die annually from malaria, most of
it caused by one species Plasmodium falciparum, with most of the deaths
among children in Sub-Saharan Africa and India.5,9
Schistosomaisis. Schistosomaisis is another helminth infection
caused by blood flukes (schistosomes) that frequently occurs together
with STH infections in children.10,18 Both STH infections and
schistosomiasis result in childhood growth delays, but schistosomiasis
also produces severe pathology to the urogenital tract and liver and
intestines.18 It has been estimated that 207 million cases occur annually
with about 90% of the cases in Africa10; however, other investigators have
suggested that the actual number could be much higher such that
schistosomiasis ranks with STH infections as the most common tropical
diseases.18
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Trachoma. Trachoma is a chronic ocular infection caused by the
intracellular bacteria Chlamydia trachomitis. It is a leading cause of
blindness in low-income countries, especially in poor rural areas of Africa,
Asia, and Central and South America, Australia, and the Middle East.11,19
It is especially common in preschool children in areas where the infection
is hyperendemic.19 Approximately 21 million cases occur worldwide, of
whom 2 million are visually impaired and one million are blind.19
Visceral Leishmaniasis (VL). VL is a systemic illness that affects
the liver, spleen, and bone marrow (reticuloendothelial system) and is
caused by parasitic intracellular protozoa of the genus Leishmania.
Between 0.2 and 0.4 million cases of VL occur worldwide, but most of the
new cases now occur in India (especially in Bihar State), Bangladesh,
Sudan and South Sudan, Ethiopia, and Brazil.12 The disease is associated
with a high mortality unless treated promptly.
Assessing the toll
Overall, these six tropical infections exert a huge impact on child health,
including more than 1.7 billion infections, almost 100 million DALYs, and
between 700,000 and 1.2 million deaths. To put some of these numbers in
perspective, the tropical diseases that disproportionately affect children
cause more DALYs than HIV/AIDS,5 and account for more than 10% of all
childhood deaths. Moreover, it is common for a child to be affected by
multiple tropical diseases at the same time. For instance, soil-transmitted
helminth and schistosomiasis co-infections are common, as are these
infections together with malaria or trachoma.20 Dengue and malaria coinfections also occur.21
Even beyond the terrible health toll from tropical infections in
childhood in terms of DALYs and deaths there is a potentially large
socioeconomic impact. There is increasing recognition that poverty is an
overriding determinant for these tropical diseases, and that these
infections actually cause poverty.22 Malaria was a key factor in thwarting
economic growth in southern Europe during the mid-twentieth century,23
while today STH infections, schistosomiasis, trachoma, VL, and dengue
are holding back the economic development of Africa and Asia.15,18,24-27
However, we are still at a relatively nascent stage of assigning specific
dollars lost annually from tropical infections, and there is not yet detailed
information on exactly how tropical diseases cause economic losses.
Major factors include losses in agricultural productivity, deficits in child
intellect and cognition, hospital and health care costs, and maternal
illness.22 Thus, while we call the six childhood infections “tropical,” they
are first and foremost diseases of extreme poverty.
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Consistent with the links between pediatric tropical infections and
poverty is a recent finding that many of the world’s tropical infections occur
mostly among the extreme poor living in emerging economies of the group
of 20 nations.28 Of the 1.2 billion of the world’s poorest people living below
the World Bank poverty line of $1.25 per day,29 approximately 50% live in
G20 countries, led by India, China, Indonesia, and Brazil. Together these
three countries account for more than 600 million people living in extreme
poverty. Thus tropical infections such as VL, STH infections, lymphatic
filariasis, food-borne trematodiases, leprosy, Chagas disease, and dengue
disproportionately occur among the poor in G20 countries.29
Pediatric tropical diseases in the United States
To emphasize even further the poverty links is an emerging story of
tropical diseases among the poor in the southern United States. More than
16 million children in the US (22% of all children) live in families living
below the federal poverty level,30 with approximately one-fifth of those
children in rural poverty.31 Of particular concern is the finding by the
University of Michigan National Poverty Center that 1.65 million
households with 3.55 million children live on less than $2 per person per
day in a given month.32 Thus sporadic pockets of poverty in the US
approach levels seen in developing countries. As shown in Figure 3, the
US ranks near the bottom of industrialized countries in terms of child
poverty rates.33
Figure 3. Relative child poverty among industrialized nations by percentage. Map
created using data from Unicef Inocenti Research Centre Report Card 10, Measuring
Child
Poverty.
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Child poverty in the US is not evenly distributed; it
disproportionately occurs in the southern states and among people of
color, especially non-Hispanic black and Hispanic children.34
We
Identified several neglected tropical diseases affecting impoverished
children in the Southern U.S., including parasitic infections such as
toxocariasis, a larval helminth infection linked to pulmonary and
neurological deficits and pathologies. 35-39 Other parasitic infections
associated with child poverty include toxoplasmosis and cysticercosis,
while impoverished adults were affected by trichomoniasis and Chagas
disease.35 A key tropical viral infection now found in the southern US is
dengue, which is linked to poverty in South Texas,35,40 while West Nile
virus infection is associated with homelessness in Texas.41 Indeed,
probably the highest prevalence of these tropical infections occurs in
Texas, where transmission of most of these diseases occurs (as opposed
to importation through immigration).42 So far two economic analyses of
tropical infections in the US have been conducted.43,44 The total costs of
Chagas disease in the US approach $900 million annually,43 while since
2002 West Nile virus infection cost $112 million in Texas alone.44
Combating tropical infections through disease control and
prevention
There is not a unified global alliance to combat all the major tropical
diseases of children, but there are pockets of success. One of the most
promising enterprises for tropical disease control has been launched
through joint efforts supported by the governments of the US and United
Kingdom through their major overseas development organizations. Both
governments are providing financial support to health ministries in Africa
and elsewhere to implement mass treatments using packages of essential
medicines that target several tropical infections affecting children,
including the STH infections, schistosomiasis, and trachoma, in addition
two parasitic infections of adults – lymphatic filariasis and
onchocerciasis.45,46 These treatments can be administered for only $0.50
per year, so that it is incredibly inexpensive and possibly as cost-effective
as vaccines, and is leading to the elimination of lymphatic filariasis,
onchocerciasis, and trachoma, while reducing the burden of disease from
STH infections and schistosomiasis.47 Currently effective programs for
large-scale control of dengue and VL are not in place. For malaria,
increased vector control and widespread implementation of insecticide
treated bednets and artemisinin combinations, in parallel with
strengthening of health systems and improved case management is
leading to reductions in malaria among young children and pregnant
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women.18 Four countries have been certified as malaria-free in the past
five years – Armenia, Morocco, Turkmenistan, and the UAE, and 34
countries have been identified as “malaria-eliminating” where the number
of cases overall has decreased by 85% between 2000 to 2010.18
According to some investigators these international efforts have shifted
the global malaria disease burden away from younger children to older
children and adults, especially adult males.18 Such efforts are also shifting
the malaria burden to migrant populations, with high levels of Plasmodium
vivax infections.18 In parallel to these control and elimination activities
international efforts are in place to conduct research and development on
new tropical disease vaccines, with vaccines for hookworm infection,
schistosomiasis, and malaria in clinical trials.47 However, vaccines are not
widely incorporated yet into global elimination strategies alongside mass
drug treatments and bednets.
Finally, in the US there is not yet widespread acknowledgement or
recognition of the tropical disease problem in the southern part of the
country. Ironically, we are further ahead of tropical disease control and
elimination efforts internationally than we are for the US.42,48
While some important successes have been achieved in terms of
scaling up mass drug administration for childhood helminth infections, ie,
STH infections and schistosomiasis, and advancing malaria elimination in
some countries, there is not yet in place an overarching policy that fully
integrates all of the major pediatric tropical diseases. Yet, in Africa, Asia,
and elsewhere there is enormous geographic overlap between the
childhood helminth infections and trachoma with the vector-borne tropical
diseases such as dengue and malaria. Beyond geographic overlap, coinfections with helminthiases and vector-borne tropical diseases are
common, in some cases leading to additive or possibly even synergistic
morbidities. Therefore, a focused international effort should be
implemented to identify both theoretical and operational mechanisms that
link prevention efforts for all of the major pediatric tropical diseases and,
ultimately, for integrating global control and elimination for these
conditions. A series of stakeholder meetings led by the WHO and their
regional offices would represent an important first step for global
integration of pediatric tropical disease control. Simultaneously, we
urgently need a policy for scaling up surveillance efforts for tropical
diseases in southern US, and implementing a new policy for these
diseases.
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